Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: According to the present disclosure, provided is a method for determining phase transition temperature using electrical conductivity. More specifically, according to the present disclosure, there is provided a method for determining phase transition temperature using electrical conductivity, including preparing a graph of the change in electrical conductivity of molten salts according to temperature, and performing at least one mathematical analysis of (i) performing a first-order differential on the graph, (ii) performing a second-order differential on the graph; and (iii) determining the number (n) of data and resolution (AT) based on the graph to derive Tn by Equation (1) below and performing linear regression analysis on a linear section to detect an outlier based on a distance from the linear regression equation, T n = T max - ? ? T × n Equation ? ( 1 ) where n denotes the number of data, and ?T denotes an interval of measurement temperature and means resolution.

Abstract: The present invention relates to a novel heterocyclic compound and a composition, for preventing or treating a cancer, an autoimmune disease, and an inflammatory disease, comprising same. The novel heterocyclic compound of the present invention is a bifunctional compound having a Bruton's tyrosine kinase (BTK) degradation function via a ubiquitin proteasome pathway, and may be utilized as a composition for preventing or treating a cancer, an autoimmune disease, and Parkinson's disease.

Abstract: The present disclosure provides: a compound of a specific chemical structure, having excellent activity with respect to BTK degradation; or a pharmaceutically acceptable salt thereof. The present disclosure also provides a composition comprising the compound or pharmaceutically acceptable salts thereof. The present disclosure also provides are pharmaceutical use for treating or preventing BTK-associated diseases (for example, autoimmune diseases or cancer) of the compound, the salt thereof, and the composition comprising same according to the present disclosure. The present disclosure also provides a method for treating or preventing BTK-associated diseases (for example, autoimmune diseases or cancer), comprising administering, to a subject requiring treatment, an effective amount of the compound, the salt thereof, or the composition comprising same according to the present disclosure.

Abstract: A battery module including a plurality of battery cells; and a spacer between the battery cells, the spacer including a support frame, and at least one pressing member coupled to the support frame, the at least one pressing member including a plate surface facing one of the battery cells and being in contact with an outside of a can of the one battery cell.

Abstract: A battery pack fire extinguishing system includes: a compressor configured to compress a refrigerant; a condenser connected to the compressor through a first conduit and configured to condense the refrigerant; an evaporator connected to the condenser through a second conduit and connected to the compressor through a third conduit, the evaporator being configured to absorb ambient heat; a battery cell on the evaporator; and a refrigerant injector connected to the second conduit, above the battery cell, and configured to melt when vent gas is discharged from a vent hole in the battery cell to inject the refrigerant into the battery cell.

Abstract: A battery module including a plurality of battery cells; and a spacer between the battery cells, the spacer including a support frame, and at least one pressing member coupled to the support frame, the at least one pressing member including a plate surface facing one of the battery cells and being in contact with an outside of a can of the one battery cell.

Abstract: A transformer includes a lower magnetic core having a lower column upwardly formed at a center thereof; an upper magnetic core having an upper column downwardly formed at a center thereof, the lower upper and magnetic cores being symmetrically coupled so that the lower and upper columns are engaged with each other; a double-sided printed circuit board being fitted through an opening formed on a center thereof around a middle of the columns and having primary coils patterned on both surfaces thereof; a lower secondary coil molded product being fitted through an opening formed on a center thereof around a lower portion of the columns and including a secondary coil embedded therein; and an upper secondary coil molded product being fitted through an opening formed at a center thereof around an upper portion of the columns and including a secondary coil embedded therein.

Abstract: The present invention relates to a coaxial cable structure for connecting to a printed circuit board including: a coaxial cable part having a plurality of signal lines, an inner insulator, a shield wire covered along the outer periphery of the inner insulator, and an outer insulator covered along the outer periphery of the shield wire; a pattern part formed on one surface of the printed circuit board, and serving as a conductor adapted to abut against the signal lines exposed to the outside of the coaxial cable part, the pattern part having the corresponding the plurality of signal lines; number of signal patterns to and a ground pattern adapted and a soldering part adapted to directly solder each the coaxial cable part portions thereof to the pattern part of signal line and exposed to the each shield wire of outside at the end the printed circuit board.